Schlumberger, M <br/><br/>
[Management of refractory thyroid cancers].  [electronic resource] 

 -  Annales d'endocrinologie  Apr 2011 
 - 149-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>2213-3941 
<br/><br/><label>Standard No.: </label>10.1016/j.ando.2011.03.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Carcinoma--drug therapy<br/>Carcinoma, Papillary<br/>Humans<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Protein Kinase Inhibitors--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Thyroid Cancer, Papillary<br/>Thyroid Neoplasms--drug therapy